نتایج جستجو برای: anti platelet

تعداد نتایج: 470767  

Journal: :Japanese Journal of Thrombosis and Hemostasis 2006

  Abstract Background and Objectives Platelet refractoriness can be caused by immunological and non-immunological factors. In non-immunological cases, the source which is usually a disease, should be eliminated. In immunological cases antibodies produced against foreign platelet antigens play a significant role. The aim of this review was to investigate the strategies involved in identifying ...

2013
Tae-Jin Song Sang Hyun Suh Pil-Ki Min Dong Joon Kim Byung Moon Kim Ji Hoe Heo Young-Dae Kim Kyung-Yul Lee

PURPOSE Cerebral ischemic lesions are frequently observed after carotid artery stenting (CAS), and anti-platelet agents are used to prevent stent thrombosis and peri-procedural complications. However, despite the premedication, cerebral ischemic lesions are observed, suggesting that they may rather be related to anti-platelet resistance. We, therefore, investigated the effects of anti-platelet ...

Journal: :Blood 2016
Connie M Arthur Seema R Patel H Cliff Sullivan Annie M Winkler Chris A Tormey Jeanne E Hendrickson Sean R Stowell

Platelet transfusion provides an important therapeutic intervention in the treatment and prevention of bleeding. However, some patients rapidly clear transfused platelets, preventing the desired therapeutic outcome. Although platelet clearance can occur through a variety of mechanisms, immune-mediated platelet removal often plays a significant role. Numerous studies demonstrate that anti-platel...

2008
Huan-Yao Lei Kao-Jean Huang Yee-Shin Lin Hsiao-Sheng Liu Trai-Ming Yeh Ching-Chuan Liu

Dengue virus infection causes dengue fever, Dengue Hemorrhagic Fever (DHF) and Dengue Shock Syndrome (DSS). Thrombocytopenia is common in dengue fever and is always found in DHF/DSS. The pathogenesis of thrombocytopenia is poorly understood. To further understand the relationship between anti-dengue virus antibody and anti-platelet antibody, we generated monoclonal anti-dengue virus antibodies ...

2011
Xuebin Ji Ming Hou

Anti-platelet therapy plays an important role in the treatment of patients with thrombotic diseases. The most commonly used anti-platelet drugs, namely, aspirin, ticlopidine, and clopidogrel, are effective in the prevention and treatment of cardio-cerebrovascular diseases. Glycoprotein IIb/IIIa antagonists (e.g., abciximab, eptifibatide and tirofiban) have demonstrated good clinical benefits an...

Journal: :Hiroshima journal of medical sciences 1989
K Oda

Chronic idiopathic thrombocytopenic purpura (chronic ITP) is an autoimmune disorder characterized by bleeding tendency and the presence of auto-antibody to platelets. Quantitative analysis of the level of anti-platelet antibodies and platelet associated antibodies is now possible. Furthermore, recent immunological techniques have enabled us to detect target platelet antigens in chronic ITP. In ...

Journal: :iranian journal of blood and cancer 0
hemmati t farsinezhad a managhchi mr toogeh g faranoush m

background: activated normal platelets undergo many biochemical and morphological changes, some of which are apoptotic. platelet derived microparticles and shrinked platelets as hallmark of platelet activation and apoptosis disperse surfaces containing procoagulant activity around injured vessels and tissues. this study was conducted to determine microparticles formation and platelet shrinkage ...

Journal: :international journal of health studies 0
majid rahmati 1 1 dept. of medical biotechnology, school of medicine, shahroud university of medical sciences, shahroud, iran. rahele khademi 2 2 dept. of medical biotechnology, school of advanced technologies in medicine, tehran university of medical sciences, tehran, iran. zohreh sharifi 3 3 iranian blood transfusion organization research center, high institute for research and education in transfusion medicine, tehran, iran. fatemeh yari 3 mohsen badalzadeh 4 4 immunology, asthma and allergy research institute, tehran university of medical sciences, tehran, iran. maryam taheri 5 5 information technology office, iranian blood transfusion organization (ibto), tehran, iran.

background: platelet mps are produced automatically during platelet storage. their size is about 0.1 – 1 µm and have ability for sub- endothelium adhering, strengthen of platelet aggregation and also platelet pre- coagulation. in fact, the release of membrane particles helps to signal to the neighbor cells or to seclude target cells from apoptosis. the purpose of this study is to determine the ...

Journal: :Blood 1993
E Atlas J Freedman V Blanchette M D Kazatchkine J W Semple

Approximately 30% to 40% of patients with acute leukemia receiving repeated pooled random-donor platelet transfusions develop anti-HLA alloantibodies. Over time, however, serum anti-HLA concentrations decrease in approximately 50% of these patients, despite continued exposure to platelet and/or red blood cell transfusions. Using an enzyme-linked immunosorbent assay to measure serum Igs, the pre...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید